Published in Arch Virol Suppl on January 01, 1993
Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol (2005) 2.24
Hepatitis B virus S gene escape mutants. Asian J Transfus Sci (2007) 1.14
Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela. J Clin Microbiol (1998) 1.10
Complete genome sequence and phylogenetic relatedness of hepatitis B virus isolates in Papua, Indonesia. J Clin Microbiol (2009) 0.93
Distribution of HBV genotypes among HBV carriers in Benin:phylogenetic analysis and virological characteristics of HBV genotype E. World J Gastroenterol (2005) 0.89
Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia. Hepat Res Treat (2011) 0.84
New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol (1972) 6.33
Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology (1994) 4.77
Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol (1993) 2.50
HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet (1994) 2.25
Transmission of hepatitis B virus by HBV-negative blood transfusion. Lancet (1995) 2.06
Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol (1992) 1.94
A new antigen-antibody system. Clinical significance in long-term carriers of hepatitis B surface antigen. JAMA (1975) 1.78
Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol Lett (1991) 1.73
Homotypic echoviruses share aminoterminal VP1 sequence homology applicable for typing. J Med Virol (2001) 1.50
Seroimmunologic classification of chronic hepatitis in 57 children. Hepatology (1983) 1.48
Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: a 5-year prospective study. AIDS (1991) 1.46
Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N Engl J Med (1982) 1.37
Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol (1992) 1.37
Complete sequencing of a gibbon hepatitis B virus genome reveals a unique genotype distantly related to the chimpanzee hepatitis B virus. Virology (1996) 1.34
Genotype F prevails in HBV infected patients of hispanic origin in Central America and may carry the precore stop mutant. J Med Virol (1997) 1.33
False-positive Western blot reactions to human immunodeficiency virus in blood donors. Lancet (1986) 1.31
A new antigen complex co-occurring with Australia antigen. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 1.27
Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen. J Med Virol (1991) 1.26
Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg (1994) 1.26
Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff. Lancet (1981) 1.21
Early detection of human immunodeficiency virus infection using third- and fourth-generation screening assays. Eur J Clin Microbiol Infect Dis (2001) 1.21
Characterization of a new antigen-antibody system associated with hepatitis B. Clin Exp Immunol (1975) 1.18
Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients. Lancet (1981) 1.18
Molecular epidemiology of hepatitis B virus in Central America reflected in the genetic variability of the small S gene. J Infect Dis (1997) 1.17
Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J Med Virol (2001) 1.15
Immunodominant regions within the hepatitis C virus core and putative matrix proteins. J Clin Microbiol (1992) 1.12
Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B. J Med Virol (1990) 1.11
A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int (1994) 1.11
Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela. J Clin Microbiol (1998) 1.10
Detection of e antigen and antibody: correlations with hapatitis B surface and hepatitis B core antigens, liver disease, and outcome in hepatitis B infections. Gastroenterology (1976) 1.09
Laboratory infection with parvovirus B19. J Clin Pathol (1988) 1.07
Antibodies to hepatitis C virus in French blood donors. Lancet (1989) 1.07
Human and murine B-cells recognize the HBeAg/beta (or HBe2) epitope as a linear determinant. Mol Immunol (1991) 1.06
Genetic relatedness of Sindbis virus strains from Europe, Middle East, and Africa. Virology (1996) 1.06
Presumed common source outbreaks of hepatitis A in an endemic area confirmed by limited sequencing within the VP1 region. J Med Virol (2001) 1.05
Immunochemical structure of the carboxy-terminal part of hepatitis B e antigen: identification of internal and surface-exposed sequences. J Gen Virol (1993) 1.04
Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees. Hepatology (2000) 1.02
Serological studies of an enterically transmitted non-A, non-B hepatitis in Somalia. J Med Virol (1993) 0.99
Enzyme immunoassay for anti-hepatitis B core (HBc) immunoglobulin G1 and significance of low-level results in competitive assays for anti-HBc. J Clin Microbiol (1989) 0.99
Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein. Clin Exp Immunol (1993) 0.99
Transfusion-transmitted viral infections. Retrovirus and Viral Hepatitis Working Groups of the French Society of Blood Transfusion. N Engl J Med (1996) 0.98
Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein. Clin Exp Immunol (1994) 0.98
Hepatitis B virus DNA in Dane particles: evidence for the presence of replicative intermediates. J Infect Dis (1985) 0.97
DNA amplification of HIV-1 in seropositive individuals and in seronegative at-risk individuals. AIDS (1990) 0.97
Viral etiology of acute childhood encephalitis in Beijing diagnosed by analysis of single samples. Pediatr Infect Dis J (1996) 0.96
Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the isotypes and the recognition site. Immunol Lett (1992) 0.96
Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors. Vox Sang (2000) 0.95
Human parvovirus and rheumatoid arthritis. Lancet (1985) 0.93
HIV-2 in blood donors and in different risk groups in France. Lancet (1987) 0.91
No clinical signs 14 years after HIV-2 transmission via blood transfusion. Lancet (1988) 0.90
High prevalence of GB virus C strains genetically related to strains with Asian origin in Nicaraguan hemophiliacs. J Med Virol (1997) 0.90
Locations of antibody binding sites within conserved regions of the hepatitis C virus core protein. J Med Virol (1994) 0.88
Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission. Eur J Clin Microbiol Infect Dis (1993) 0.88
[Screening tests combined with p24 antigen and anti-HIV antibodies in early detection of HIV-1]. Transfus Clin Biol (2000) 0.87
Familial human parvovirus infections. Lancet (1985) 0.87
Monoclonal antibodies to HBsAg: a study of their specificities for eight different HBsAg subtypes. Dev Biol Stand (1983) 0.87
Human parvovirus and aplastic crisis in chronic hemolytic anemias: a study of 24 observations. Am J Hematol (1986) 0.87
Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA. J Med Virol (2001) 0.85
Surveillance of equine influenza viruses through the RESPE network in France from November 2005 to October 2010. Equine Vet J (2013) 0.85
Typing of hepatitis B virus genomes by a simplified polymerase chain reaction. J Med Virol (1990) 0.85
Detection of IgA class antibody to hepatitis E virus in serum samples from patients with hepatitis E virus infection. J Med Virol (1993) 0.84
[Parvovirus (serum-parvovirus-like-virus) and Aurillac antigen. A study of 18 cases]. Rev Fr Transfus Immunohematol (1984) 0.84
Hepatitis B "e" antigen: an apparent association with lactate dehydrogenase isozyme-5. Science (1977) 0.84
Detection of antibodies to human immunodeficiency virus type 2 (HIV-2) in blood donor sera using United States assay methods for anti-HIV type 1. Transfusion (1992) 0.84
Autoantibodies to the basal cells of squamous epithelium react with thymic epithelial cells. Clin Immunol Immunopathol (1985) 0.83
Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre. Nephrol Dial Transplant (1999) 0.83
[Prevalence of HIV, HTLV, and hepatitis B and C viruses in blood donors in France, 1992-1996]. Transfus Clin Biol (1998) 0.83
Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV. AIDS (1988) 0.83
Molecular epidemiology and variation of hepatitis B in recent immigrant families to Australia. J Med Virol (1998) 0.81
Rapid progression to AIDS in dual HIV-1/HTLV-I infection. Lancet (1990) 0.81
Genetic conservation within subtypes in the hepatitis B virus pre-S2 region. J Gen Virol (1994) 0.81
Immune recognition of linear antigenic regions within the hepatitis B pre-C and C-gene translation products using synthetic peptides. J Med Virol (1994) 0.81
Parvovirus and idiopathic thrombocytopenic purpura. Lancet (1989) 0.80
Immunogenicity of the recombinant GenHevac B Pasteur vaccine against hepatitis B in chronic uremic patients. J Infect Dis (1994) 0.80
Antibody to hepatitis C (anti C 100-3) in French hemophiliacs. Nouv Rev Fr Hematol (1991) 0.80
Detection of HBV DNA by PCR in serum from an HBsAg negative blood donor implicated in cases of post-transfusion hepatitis B. Arch Virol Suppl (1992) 0.80
Progression to AIDS in the majority of asymptomatic HIV-infected people. AIDS (1989) 0.80
Immunoglobulin G antibodies to lymphadenopathy-associated virus in differently treated French and Belgian hemophiliacs. Ann Intern Med (1985) 0.80
Two successive HIV contaminations from subjects in the window period. AIDS (1998) 0.80
[Recombinant vaccine and extracting vaccine against hepatitis B in patients with kidney insufficiency: comparative immunogenicity]. Presse Med (1994) 0.80
Autoantibodies to thymic epithelial cells in hepatitis B virus-associated delta infection. J Infect Dis (1985) 0.79
High frequency of hepatitis B virus DNA in anti-HBe positive sera on longitudinal follow-up of patients with renal transplants and chronic hepatitis B. J Med Virol (1989) 0.79
The a(w) subdeterminants. Bibl Haematol (1976) 0.79
IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B. Clin Exp Immunol (1991) 0.79
Serological evidence of successive HIV-2 and HIV-1 infections in a bisexual man. AIDS (1992) 0.79
Blood donor screening or 'over-screening': how far to go in avoiding transmission of infectious agents? Vox Sang (1992) 0.79